Thor Energy lifted by hydrogen project update

Impact · against what's priced in

Thor Energy and Imaging Biometrics both provide material positive updates that increase the probability of success for their primary assets. Thor Energy's discovery of high-concentration hydrogen significantly increases the likelihood of a commercial find, while Imaging Biometrics hits a critical safety milestone in its glioblastoma treatment.

THR+0.60

No priced-in read yet

In context

The recording of natural hydrogen readings up to 3% (60,000x background levels) and the shift toward 2D seismic work to define drilling targets significantly increases the asset's maturity and probability of commercial discovery.

Read from the article alone

• biotech
• IBAI
• THR
• australia
• clinical trials
• glioblastoma
• hydrogen
• mining
• pharma
• small cap

Search tags